 risk Pneumocystis carinii pneumonia human immunodeficiency virus-infected children Effective prophylaxis exists Pneumocystis carinii pneumonia major cause illness death human immunodeficiency virus-infected children adults adults /L risk Pneumocystis carinii clinical laboratory markers high risk children human immunodeficiency virus chart review infants human immunodeficiency virus infection children Pneumocystis carinii pneumonia infants months Pneumocystis carinii pneumonia normal adult standards contrast increased serum IgG levels children human immunodeficiency virus children Pneumocystis carinii pneumonia IgG levels g/L patients pre-existing symptoms consistent human immunodeficiency virus infection episode Pneumocystis carinii pneumonia addition clinical symptoms low IgG levels counts age children risk Pneumocystis carinii pneumonia candidates prophylaxis Prophylaxis infants age months proven clinical symptoms compatible human immunodeficiency virus infection children months /L predictive risk Pneumocystis carinii pneumonia children prophylaxis